Polysaccharides from natural resource: ameliorate type 2 diabetes mellitus via regulation of oxidative stress network

Li-Ying He1, Yong Li1, Shu-Qi Niu2,3

  • 1Key Laboratory of Characteristic Chinese Medicine Resources in Southwest China, College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

PubMed

Insights

Natural polysaccharides show promise for managing diabetes by combating oxidative stress. This review details their structures and mechanisms, offering insights for developing new diabetes treatments.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Nutrition Science

Background:

  • Diabetes mellitus (DM) is a metabolic disorder marked by hyperglycemia.
  • Oxidative stress is a key factor in the development of type 2 diabetes mellitus (T2DM) and metabolic syndrome.
  • Natural polysaccharides are complex carbohydrates with potential therapeutic benefits.

Purpose of the Study:

  • To summarize natural polysaccharides with therapeutic potential for diabetes over the last five years.
  • To elucidate the pharmacological mechanisms and primary structures of these polysaccharides.
  • To provide a reference for polysaccharide application and the development of novel anti-diabetic drugs.

Main Methods:

  • Literature review of natural polysaccharides and their effects on diabetes.
  • Analysis of studies published within the last five years.
  • Focus on structural characterization and pharmacological mechanisms.

Main Results:

  • Numerous natural polysaccharides from plants, microbes, marine organisms, and animals exhibit antioxidant and anti-diabetic properties.
  • Detailed structural information and mechanisms of action are increasingly being identified.
  • Polysaccharides demonstrate significant therapeutic potential in managing hyperglycemia and related complications.

Conclusions:

  • Natural polysaccharides represent a promising avenue for diabetes management.
  • Further research into their structures and mechanisms can accelerate the development of new anti-diabetic therapies.
  • This review consolidates current knowledge, aiding future drug discovery efforts.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.3K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
317
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
208
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
996